开云app官网登录入口网页版-官方正版

#透明细胞癌#

34篇内容 | 1486人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2196509, encodeId=d8f92196509f9, content=<a href='/topic/show?id=7c328264677' target=_blank style='color:#2F92EE;'>#肾细胞癌#</a> <a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a> <a href='/topic/show?id=e7d110818418' target=_blank style='color:#2F92EE;'>#肺多发结节#</a>, objectTitle=罕见病例：这是一种什么癌？居然手术根治切除后18年还会出现转移！, objectType=article, longId=818487, objectId=1ffd81848e59, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/health-insurance-PK235DP.jpg, objectUrl=/article/show_article.do?id=1ffd81848e59, replyNumber=0, likeNumber=76, createdTime=2024-04-01, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=1ffd81848e59, moduleTitle=罕见病例：这是一种什么癌？居然手术根治切除后18年还会出现转移！, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=1ffd81848e59)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2010077, encodeId=fa0420100e759, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=辅助放疗对早期卵巢透明细胞癌患者生存的影响, objectType=article, longId=724864, objectId=4eace2486473, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4eace2486473, replyNumber=0, likeNumber=85, createdTime=2023-02-28, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4eace2486473, moduleTitle=辅助放疗对早期卵巢透明细胞癌患者生存的影响, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=4eace2486473)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010080, encodeId=cb31201008015, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=浙江大学在《Cell Discovery》发文揭示肾透明细胞癌中的关键调控程序, objectType=article, longId=733515, objectId=3affe33515af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3affe33515af, replyNumber=0, likeNumber=67, createdTime=2023-01-31, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3affe33515af, moduleTitle=浙江大学在《Cell Discovery》发文揭示肾透明细胞癌中的关键调控程序, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=3affe33515af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010081, encodeId=32bc2010081ea, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=Lancet Oncol：派姆单抗单药辅助治疗术后高复发风险的肾透明细胞癌, objectType=article, longId=737794, objectId=6a68e377947e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a68e377947e, replyNumber=0, likeNumber=76, createdTime=2023-04-24, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a68e377947e, moduleTitle=Lancet Oncol：派姆单抗单药辅助治疗术后高复发风险的肾透明细胞癌, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=6a68e377947e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010078, encodeId=1f4020100e8d1, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=Clin Cancer Res：MEDI0680+Durvalumab vs 纳武单抗治疗晚期肾透明细胞癌, objectType=article, longId=726302, objectId=68e5e26302bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68e5e26302bd, replyNumber=0, likeNumber=107, createdTime=2022-05-21, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68e5e26302bd, moduleTitle=Clin Cancer Res：MEDI0680+Durvalumab vs 纳武单抗治疗晚期肾透明细胞癌, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=68e5e26302bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010074, encodeId=782320100e44f, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=European Urology：Lenvatinib联合依维莫司治疗晚期肾非透明细胞癌，客观缓解率达26%！, objectType=article, longId=215161, objectId=574121516111, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=574121516111, replyNumber=0, likeNumber=55, createdTime=2021-11-06, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=574121516111, moduleTitle=European Urology：Lenvatinib联合依维莫司治疗晚期肾非透明细胞癌，客观缓解率达26%！, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=574121516111)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010079, encodeId=1ec520100e941, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=Clin Cancer Res：MEDI0680联合杜瓦鲁单抗治疗晚期肾透明细胞癌, objectType=article, longId=729652, objectId=3bf0e296528c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3bf0e296528c, replyNumber=0, likeNumber=73, createdTime=2023-04-05, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3bf0e296528c, moduleTitle=Clin Cancer Res：MEDI0680联合杜瓦鲁单抗治疗晚期肾透明细胞癌, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=3bf0e296528c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010076, encodeId=2d2020100e62d, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=Lancet Oncol：转移性肾透明细胞癌的三种一线治疗方案的疗效和安全性, objectType=article, longId=723824, objectId=cc6fe23824f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc6fe23824f3, replyNumber=0, likeNumber=93, createdTime=2022-07-26, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc6fe23824f3, moduleTitle=Lancet Oncol：转移性肾透明细胞癌的三种一线治疗方案的疗效和安全性, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=cc6fe23824f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010075, encodeId=1ed720100e571, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=Front Oncol：早期子宫内膜透明细胞癌患者行系统淋巴结切除术可改善患者预后, objectType=article, longId=301740, objectId=1ac9301e4007, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ac9301e4007, replyNumber=0, likeNumber=53, createdTime=2022-12-24, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ac9301e4007, moduleTitle=Front Oncol：早期子宫内膜透明细胞癌患者行系统淋巴结切除术可改善患者预后, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=1ac9301e4007)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010073, encodeId=0c7520100e395, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=Radiology:扩散加权MRI成像，使VHL相关性肾透明细胞癌的个性化检测成为可能, objectType=article, longId=212581, objectId=94af212581cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94af212581cc, replyNumber=0, likeNumber=53, createdTime=2021-09-13, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94af212581cc, moduleTitle=Radiology:扩散加权MRI成像，使VHL相关性肾透明细胞癌的个性化检测成为可能, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=94af212581cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010071, encodeId=e58f20100e1af, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=JCO：帕博利珠单抗一线治疗进展期肾透明细胞癌患者一线治疗的ORR可达36.4％, objectType=article, longId=206737, objectId=4e1b206e376a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e1b206e376a, replyNumber=0, likeNumber=94, createdTime=2021-10-26, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e1b206e376a, moduleTitle=JCO：帕博利珠单抗一线治疗进展期肾透明细胞癌患者一线治疗的ORR可达36.4％, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=4e1b206e376a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010072, encodeId=805220100e29c, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=ASCO GU 2021: HIF-2α抑制剂Belzutifan在晚期肾透明细胞癌中初显疗效, objectType=article, longId=207202, objectId=75d220e20291, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75d220e20291, replyNumber=0, likeNumber=96, createdTime=2021-06-08, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75d220e20291, moduleTitle=ASCO GU 2021: HIF-2α抑制剂Belzutifan在晚期肾透明细胞癌中初显疗效, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=75d220e20291)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010070, encodeId=a9d220100e071, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=Nat Commun：HIF-1α和HIF-2α在肾透明细胞癌中发挥相反的调节作用, objectType=article, longId=200254, objectId=83ff20025423, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83ff20025423, replyNumber=0, likeNumber=75, createdTime=2021-06-04, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83ff20025423, moduleTitle=Nat Commun：HIF-1α和HIF-2α在肾透明细胞癌中发挥相反的调节作用, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=83ff20025423)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010068, encodeId=3071201006857, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=ASCO 2020：K药联合仑伐替尼的“可乐组合”在肾透明细胞癌再显威, objectType=article, longId=195028, objectId=3b871950281b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b871950281b, replyNumber=0, likeNumber=0, createdTime=2021-02-11, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b871950281b, moduleTitle=ASCO 2020：K药联合仑伐替尼的“可乐组合”在肾透明细胞癌再显威, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=3b871950281b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010067, encodeId=ea72201006ea7, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=肾透明细胞癌预后风险评分(GRANT得分), objectType=article, longId=194817, objectId=938619481e29, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=938619481e29, replyNumber=0, likeNumber=43, createdTime=2020-08-01, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=938619481e29, moduleTitle=肾透明细胞癌预后风险评分(GRANT得分), moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=938619481e29)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010065, encodeId=fc64201006504, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=Cell | 肾透明细胞癌的整合蛋白基因组学研究, objectType=article, longId=182263, objectId=360b18226369, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=360b18226369, replyNumber=0, likeNumber=85, createdTime=2019-12-12, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=360b18226369, moduleTitle=Cell | 肾透明细胞癌的整合蛋白基因组学研究, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=360b18226369)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010066, encodeId=fa3a2010066b1, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=Lancet oncol：为何透明细胞癌肥胖患者预后优于正常体重患者？, objectType=article, longId=185279, objectId=7b0b1852e9a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b0b1852e9a9, replyNumber=0, likeNumber=69, createdTime=2020-07-01, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b0b1852e9a9, moduleTitle=Lancet oncol：为何透明细胞癌肥胖患者预后优于正常体重患者？, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=7b0b1852e9a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010069, encodeId=c9ab2010069a2, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=Lancet Oncol：肾透明细胞癌与肥胖悖论相关的转录组特征分析, objectType=article, longId=199538, objectId=8bfb199538ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8bfb199538ea, replyNumber=0, likeNumber=85, createdTime=2020-11-04, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8bfb199538ea, moduleTitle=Lancet Oncol：肾透明细胞癌与肥胖悖论相关的转录组特征分析, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=8bfb199538ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010064, encodeId=526b2010064db, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=Clinica Chimica Acta：靶向测序检测卵巢癌透明细胞癌中ARID1A和PIK3CA的高频突变, objectType=article, longId=177306, objectId=0ffd1e730650, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ffd1e730650, replyNumber=0, likeNumber=74, createdTime=2020-05-31, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ffd1e730650, moduleTitle=Clinica Chimica Acta：靶向测序检测卵巢癌透明细胞癌中ARID1A和PIK3CA的高频突变, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=0ffd1e730650)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010062, encodeId=5c282010062bd, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=CLIN CANCER RES：mTORC1/2阻断可以用于治疗卵巢透明细胞癌, objectType=article, longId=147728, objectId=4fcc14e72887, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4fcc14e72887, replyNumber=0, likeNumber=71, createdTime=2018-11-10, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4fcc14e72887, moduleTitle=CLIN CANCER RES：mTORC1/2阻断可以用于治疗卵巢透明细胞癌, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=4fcc14e72887)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

透明细胞癌

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#肾细胞癌# #透明细胞癌# #肺多发结节#

罕见病例：这是一种什么癌？居然手术根治切除后18年还会出现转移！

2024-04-01发表于陕西省

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

辅助放疗对早期卵巢透明细胞癌患者生存的影响

2023-02-28

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

浙江大学在《Cell Discovery》发文揭示肾透明细胞癌中的关键调控程序

2023-01-31

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

Lancet Oncol：派姆单抗单药辅助治疗术后高复发风险的肾透明细胞癌

2023-04-24

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

Clin Cancer Res：MEDI0680+Durvalumab vs 纳武单抗治疗晚期肾透明细胞癌

2022-05-21

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

European Urology：Lenvatinib联合依维莫司治疗晚期肾非透明细胞癌，客观缓解率达26%！

2021-11-06

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

Clin Cancer Res：MEDI0680联合杜瓦鲁单抗治疗晚期肾透明细胞癌

2023-04-05

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

Lancet Oncol：转移性肾透明细胞癌的三种一线治疗方案的疗效和安全性

2022-07-26

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

Front Oncol：早期子宫内膜透明细胞癌患者行系统淋巴结切除术可改善患者预后

2022-12-24

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

Radiology:扩散加权MRI成像，使VHL相关性肾透明细胞癌的个性化检测成为可能

2021-09-13

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

JCO：帕博利珠单抗一线治疗进展期肾透明细胞癌患者一线治疗的ORR可达36.4％

2021-10-26

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

ASCO GU 2021: HIF-2α抑制剂Belzutifan在晚期肾透明细胞癌中初显疗效

2021-06-08

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

Nat Commun：HIF-1α和HIF-2α在肾透明细胞癌中发挥相反的调节作用

2021-06-04

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

ASCO 2020：K药联合仑伐替尼的“可乐组合”在肾透明细胞癌再显威

2021-02-11

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

肾透明细胞癌预后风险评分(GRANT得分)

2020-08-01

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

Cell | 肾透明细胞癌的整合蛋白基因组学研究

2019-12-12

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

Lancet oncol：为何透明细胞癌肥胖患者预后优于正常体重患者？

2020-07-01

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

Lancet Oncol：肾透明细胞癌与肥胖悖论相关的转录组特征分析

2020-11-04

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

Clinica Chimica Acta：靶向测序检测卵巢癌透明细胞癌中ARID1A和PIK3CA的高频突变

2020-05-31

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

CLIN CANCER RES：mTORC1/2阻断可以用于治疗卵巢透明细胞癌

2018-11-10

科室
- - 订阅+
  - 更多科室
工具
服务